Inflammation contributes to many chronic conditions. It is often associated with circulating
pro-inflammatory cytokines and immune cells. GLP-1 levels correlate with disease severity …

Obesity and type 2 diabetes mellitus (T2DM) are increasing in prevalence owing to
decreases in physical activity levels and a shift to diets that include addictive and/or high …

Obesity-associated inflammation is a systemic process that affects all metabolic organs.
Prominent among these is adipose tissue, where cells of the innate and adaptive immune …

Parkinson's disease (PD) is the second most common age-associated neurodegenerative
disorder and is characterised by progressive loss of dopamine neurons in the substantia …

Patients with type 2 diabetes mellitus (T2DM) are at increased risk of severe coronavirus
disease 2019 (COVID-19) outcomes possibly because of dysregulated inflammatory …

Objectives To investigate low-grade inflammation in type 2 diabetes and explore
associations to clinical aspects as well as microvascular and macrovascular complications …

There are no effective targeted therapies to treat acute respiratory distress syndrome
(ARDS). Recently, the commonly used diabetes and obesity medications, glucagon-like …

Anti-inflammatory effects of glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment
in T2D may contribute to the cardiovascular benefits observed with GLP-1 RAs in outcome …

Chronic kidney disease (CKD) affects around 10% of the global population and is most often
caused by diabetes. Diabetes with CKD (diabetic kidney disease, DKD) is a progressive …

A senescence-associated secretory phenotype (SASP) and a mild inflammatory response
characteristic of senescent cells (inflammaging) form the conditions for the development of …